← Leaderboards
Steven Van Dyken
Washington University
$3,349,915
Attributed
$4,571,054
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,571,054 · 3
By mechanism
R01$4,143,220 · 2
R21$427,834 · 1
Top collaborators
- Brian Kim3 shared
Most similar at Washington University
Same institution · by research overlap
- Marco Colonna$45,277,211
- Jeffrey Alan Magee$6,072,466
- Brian Kim$11,425,579
- Gabriel Alejandro De Erausquin$22,131,859
- David A. Rosen$4,614,307
Others in their field
Other Emerging Leaders on “Response”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$195,683,539
- Kimberly Smith · Ppd Development Lp$115,671,664
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
Research focus
ResponseAcuteMediatingNovel Therapeutic InterventionLungInnovationMouse ModelChronicDesignKnock-OutCellsSourceTissuesIn VivoMouse StrainsPathogenesisDepositionInflammatoryMolecularFunctional DisorderLinkChitinaseAge RelatedGain Of Function
Grant awards (9)
Defining the role of IL-18 in atopic dermatitis$809,010
R01 · FY2025 · AI · contact PI
Defining the role of IL-18 in atopic dermatitis$809,010
R01 · FY2024 · AI · contact PI
Chitin and chitinases in SARS-CoV-2 infection$233,250
R21 · FY2024 · AI · contact PI
Defining the role of IL-18 in atopic dermatitis$824,258
R01 · FY2023 · AI · contact PI
Targeting chitin in fibrotic lung disease$421,780
R01 · FY2023 · HL · contact PI
Chitin and chitinases in SARS-CoV-2 infection$194,584
R21 · FY2023 · AI · contact PI
Targeting chitin in fibrotic lung disease$421,780
R01 · FY2022 · HL · contact PI
Targeting chitin in fibrotic lung disease$421,780
R01 · FY2021 · HL · contact PI
Targeting chitin in fibrotic lung disease$435,602
R01 · FY2020 · HL · contact PI